Drug profile · INN
thyrotropin alfa
THYROGEN
thyrotropin alfa (THYROGEN) is a thyroid stimulating hormone receptor agonist. Associated with Sanofi-aventis Healthcare Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — thyrotropin alfa
- US status
- approved
- Class
- Systemic hormonal preparations (H01)
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
thyrotropin alfa (THYROGEN) is a thyroid stimulating hormone receptor agonist. Associated with Sanofi-aventis Healthcare Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Thyroid stimulating hormone receptor agonist
Primary target: Thyrotropin receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| TGA | approved | — |
Related & competitor drugs
Frequently asked questions
What is thyrotropin alfa?
thyrotropin alfa (THYROGEN) is a thyroid stimulating hormone receptor agonist. Associated with Sanofi-aventis Healthcare Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for thyrotropin alfa?
THYROGEN is a marketed brand name for thyrotropin alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of thyrotropin alfa?
thyrotropin alfa has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.